1. Home
  2. LEDS vs LNAI Comparison

LEDS vs LNAI Comparison

Compare LEDS & LNAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SemiLEDS Corporation

LEDS

SemiLEDS Corporation

HOLD

Current Price

$1.85

Market Cap

20.3M

Sector

Technology

ML Signal

HOLD

Logo Lunai Bioworks Inc. Common Stock

LNAI

Lunai Bioworks Inc. Common Stock

N/A

Current Price

$1.29

Market Cap

23.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LEDS
LNAI
Founded
2005
N/A
Country
Taiwan
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.3M
23.9M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
LEDS
LNAI
Price
$1.85
$1.29
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
31.1K
3.3M
Earning Date
01-09-2026
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$43,009,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
729.81
N/A
52 Week Low
$1.20
$0.81
52 Week High
$3.37
$21.00

Technical Indicators

Market Signals
Indicator
LEDS
LNAI
Relative Strength Index (RSI) 36.18 N/A
Support Level $1.71 N/A
Resistance Level $2.43 N/A
Average True Range (ATR) 0.19 0.00
MACD -0.07 0.00
Stochastic Oscillator 15.48 0.00

Price Performance

Historical Comparison
LEDS
LNAI

About LEDS SemiLEDS Corporation

SemiLEDs Corp develops, manufactures, and sells light-emitting diode chips and LED components. The company's products include LED Chips, LED Components, and Lighting Products. Its products are used for general lighting applications, including street lights and commercial, industrial, system, and residential lighting; specialty industrial applications, such as ultraviolet, or Ultraviolet, curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, LED lighting for horticulture applications, architectural lighting and entertainment lighting. Substantial revenue is generated from the sale of LED components products. Geographically, it derives a majority of its revenue from Japan.

About LNAI Lunai Bioworks Inc. Common Stock

Lunai Bioworks Inc is a biopharmaceutical company. Through its subsidiaries, it is mainly focused on developing allogeneic cell and gene therapies to promote stronger immune system responses, potentially for long-term or life-long cancer remission in some of the deadliest cancers. The group is engaged in the development of RENB-DC11 and RENB-DC20 (potential cell therapeutic vaccine candidates for different types of cancer); a proprietary AI platform that analyzes genetics to provide earlier and more accurate cancer diagnosis; and machine learning pipelines that harmonize and analyze complex, heterogeneous datasets to uncover clinically actionable insights. The group's reportable segments are: RENB, BioSymetrics, and RENC. Geographically, it operates in the United States and Netherlands.

Share on Social Networks: